Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine Nasal Spray for Sleep and Postoperative Neurocognitive Outcomes in Elderly Surgical Patients
ChiCTR2300077614Phase 4Recruiting
- Sponsor
- Affiliated Hospital of Guizhou Medical University
- Start
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Insomnia, perioperative neurocognitive disorder, postoperative delirium (POD) and 1 more comparing Dexmedetomidine nasal spray with Placebo nasal spray (2 arms). Primary endpoint: postoperative delirium incidence. Started Nov 2023; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
Insomniaperioperative neurocognitive disorderpostoperative delirium (POD)post-operative cognitive decline (POCD)
Beyond the preview
Go deeper on ChiCTR2300077614.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300077614.